Related Experiment Video
Updated: May 9, 2026
07:27
Olfactory Assays for Mouse Models of Neurodegenerative Disease
Published on: August 25, 2014
A brief olfactory test for Alzheimer's disease
Jennifer J Stamps1, Linda M Bartoshuk, Kenneth M Heilman
1Department of Neuroscience, The Clinical and Translational Science Institute, University of Florida, College of Medicine, Gainesville, FL, USA.
Journal of the Neurological Sciences
|August 10, 2013
Summary
Early Alzheimer's disease (AD) diagnosis is crucial. A simple olfactory test shows reduced odor detection in the left nostril for AD patients, aiding in early diagnosis.
Area of Science:
- Neurology
- Neuroscience
- Olfactory Science
Background:
- Early diagnosis of Alzheimer's disease (AD) is vital for reducing disability and improving quality of life.
- AD pathology initially affects olfactory cortex regions, often with greater left-hemisphere degeneration.
- Olfactory epithelium's projection to the ipsilateral olfactory cortex suggests potential asymmetrical odor detection deficits in AD.
Purpose of the Study:
- To assess a quick, non-invasive olfactory test for diagnosing probable Alzheimer's disease (AD).
- To investigate olfactory sensitivity differences between nostrils in individuals with AD, mild cognitive impairment (MCI), other dementia (OD), and controls (OC).
Main Methods:
- A retrospective, case-control study involving participants with probable AD (N=18), MCI (N=24), OD (N=26), and matched OC (N=26).
- Odor detection threshold was measured for each nostril individually using peanut butter, with the container moved incrementally during exhalation.
- The distance for odor detection was recorded for each nostril.
Main Results:
- Patients with probable AD exhibited significantly reduced odor detection distance in their left nostril (mean 5.1cm) compared to controls and other groups.
- The mean left-right nostril odor detection difference was markedly asymmetrical in AD patients (-12.4cm), distinguishing them from MCI, OD, and OC groups.
- Mild cognitive impairment (MCI) and other dementia (OD) groups showed less pronounced left-right differences, while controls had no significant asymmetry.
Conclusions:
- A simple, non-invasive, and inexpensive left-right nostril odor detection test demonstrates sensitivity and specificity for diagnosing probable AD.
- This olfactory test offers a promising tool for early and accessible Alzheimer's disease detection.
- Asymmetrical olfactory deficits, particularly in the left nostril, may serve as an early biomarker for Alzheimer's disease.
Related Concept Videos
01:25Olfaction
The sense of smell is achieved through the activities of the olfactory system. It starts when an airborne odorant enters the nasal cavity and reaches olfactory epithelium (OE). The OE is protected by a thin layer of mucus, which also serves the purpose of dissolving more complex compounds into simpler chemical odorants. The size of the OE and the density of sensory neurons varies among species; in humans, the OE is only about 9-10 cm2.
The olfactory receptors are embedded in the cilia of the...
The olfactory receptors are embedded in the cilia of the...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:03Olfactory Receptors: Location and Structure
The process of olfaction, also known as the sense of smell, is a sophisticated chemical response system. The specialized sensory neurons that facilitate this process, known as olfactory receptor neurons, are situated in an upper segment of the nasal cavity, known as the olfactory epithelium. Olfactory sensory neurons are bipolar, with their dendrites extending from the epithelium's apex into the mucus that lines the nasal cavity. Airborne molecules, when inhaled, traverse the olfactory...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...